LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)
$5.65 0 (0%)
Analysed LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) News Sources
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22-04-2026
yahoo.com
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)
27-04-2026
yahoo.com
Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026
29-04-2026
yahoo.com
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
06-05-2026
yahoo.com
Lifecore Biomedical Q1 Earnings Call Highlights
06-05-2026
marketbeat.com
Lifecore Biomedical to Participate at CDMO Live Europe
12-05-2026
yahoo.com
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
21-05-2026
yahoo.com
How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations
29-05-2026
yahoo.com
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
02-06-2026
yahoo.com
Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook
13-06-2026
yahoo.com
What is the current price of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The current price of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is $5.65.
LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) since the previous trading day is $0.
LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The most recent average sentiment score for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)?
The most recent sentiment for LIFECORE BIOMEDICAL INC (LFCR:NASDAQ) is .
SEC-8K** Filing Available For LIFECORE BIOMEDICAL INC (LFCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.